Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCapital LeasesCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Organogenesis Holdings (ORGO) Long-Term Investments: 2016-2018

Historic Long-Term Investments for Organogenesis Holdings (ORGO) over the last 2 years, with Sep 2018 value amounting to $316.3 million.

  • Organogenesis Holdings' Long-Term Investments rose 1.48% to $316.3 million in Q3 2018 from the same period last year, while for Sep 2018 it was $316.3 million, marking a year-over-year increase of 1.48%. This contributed to the annual value of $312.5 million for FY2017, which is 0.81% up from last year.
  • As of Q3 2018, Organogenesis Holdings' Long-Term Investments stood at $316.3 million, which was up 0.46% from $314.8 million recorded in Q2 2018.
  • Organogenesis Holdings' Long-Term Investments' 5-year high stood at $316.3 million during Q3 2018, with a 5-year trough of $310.0 million in Q4 2016.
  • For the 3-year period, Organogenesis Holdings' Long-Term Investments averaged around $312.4 million, with its median value being $312.1 million (2017).
  • Data for Organogenesis Holdings' Long-Term Investments shows a peak YoY climbed of 1.48% (in 2018) over the last 5 years.
  • Organogenesis Holdings' Long-Term Investments (Quarterly) stood at $310.0 million in 2016, then grew by 0.81% to $312.5 million in 2017, then increased by 1.48% to $316.3 million in 2018.
  • Its Long-Term Investments stands at $316.3 million for Q3 2018, versus $314.8 million for Q2 2018 and $313.2 million for Q1 2018.